Morning Jolt: Great News on the Vaccine Front

On the menu today: Moderna announces their coronavirus vaccine works and will be easier to store and transport than Pfizer’s; the Georgia recount is almost done; and a sneak preview of Hunting Four Horsemen about how regularly human beings come in contact with new viruses.

What's Better Than One Effective COVID-19 Vaccine? Two Effective Vaccines!

Arguably even better news than hearing that Pfizer's coronavirus vaccine is 90 percent effective: The pharmaceutical company Moderna announced this morning that the company's "experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage clinical trial" and — this has big consequences for shipping and distribution — it can be stored in regular refrigerator temperatures.

Stéphane Bancel, CEO of Moderna, said in a released statement, "This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people ...

WITH JIM GERAGHTY November 16 2020 WITH JIM GERAGHTY November 16 2020 Great News on the Vaccine Front On the menu today: Moderna announces their coronavirus vaccine works and will be easier to store and transport than Pfizer’s; the Georgia recount is almost done; and a sneak preview of Hunting Four Horsemen about how regularly human beings come in contact with new viruses. What's Better Than One Effective COVID-19 Vaccine? Two Effective Vaccines! Arguably even better news than hearing that Pfizer's coronavirus vaccine is 90 percent effective: The pharmaceutical company Moderna announced this morning that the company's "experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage clinical trial" and — this has big consequences for shipping and distribution — it can be stored in regular refrigerator temperatures. Stéphane Bancel, CEO of Moderna, said in a released statement, "This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people ...   READ MORE

ADVERTISEMENT Trending on National Review 1. 'Macho, macho man,' &c. 2. Confirm Judy Shelton to the Fed Board of Governors 3. The Case against Judy Shelton at the Federal Reserve Top Stories John Loftus The Online Learning Crisis Online learning will only accelerate the decay of America's education standards and student ... Ben Murrey How Colorado Voters Cut Taxes During a Statewide Blue Wave While voters approved a straightforward income-tax cut and a check on the creation of large new government fees, ... NEWS Cuomo Threatens to Sue Trump Admin. to Ensure Vaccine Is Distributed to 'Black and Brown... The governor claimed the inequities in the plan are made worse by a lack of federal aid to aid states in ... Jimmy Quinn Pompeo Kicks Off Post-Election Foreign Trip, in Low-Key Style The trip appears intended to highlight the Trump administration's foreign policy ... Aleksandr Solzhenitsyn Wolves and Ephemerality Aleksandr Solzhenitsyn encounters a pair of Canadian wolves at his home in Cavendish, Vt., while in exile in the ... NEWS Moderna Says Coronavirus Vaccine Is Nearly 95 Percent Effective, Trial Data Shows The drug maker is the second to announce an extremely high success rate for its experimental vaccine. PODCASTS Episode 105: Litigation Exhaustion Episode 277: Show Me the Evidence PHOTOS SpaceX Launches Crew-1 Ancient Egyptian Sarcophagi VIDEO Fauci Says the U.S. Has... Media Figures Cheer... NRPLUS ARTICLES Florida Restaurateurs Warn... Stained-Glass Masters: John La... Ready for Election Season? National Review subscribers get the most out of National Review. Don't miss out. SEE MY OPTIONS ADVERTISEMENT Follow Us & Share 19 West 44th Street, Suite 1701, New York, NY, 10036, USA Your Preferences | Unsubscribe | Privacy View this e-mail in your browser.